Abstract
Antimicrobial resistance among Gram-negatives is increasing; treatment options are limited. Although tigecycline is used infrequently for urinary tract infection (UTI), greater use is likely as resistance increases. We report successful treatment of an episode of febrile UTI and probable prostatitis with tigecycline, and summarize the relevant literature.
Original language | English (US) |
---|---|
Pages (from-to) | 168-170 |
Number of pages | 3 |
Journal | Journal of Chemotherapy |
Volume | 23 |
Issue number | 3 |
DOIs | |
State | Published - Jun 2011 |
Keywords
- Extended-spectrum beta-lactamase
- Resistance
- Tigecycline
- Urinary tract infection